Low-Key Start For Bush's Science Panel

WASHINGTON--Although it's been touted as the first scientific group to report to the president in 15 years and a symbol of George Bush's commitment to science, the President's Council of Advisers on Science and Technology was sworn in last month with little pomp and circumstance. With barely two hours' notice to the press and no written descriptions of the backgrounds of its 12 prominent members, Vice President Dan Quayle administered the oath of office and then, after a few comments, left wit

Written byElizabeth Pennisi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON--Although it's been touted as the first scientific group to report to the president in 15 years and a symbol of George Bush's commitment to science, the President's Council of Advisers on Science and Technology was sworn in last month with little pomp and circumstance.

With barely two hours' notice to the press and no written descriptions of the backgrounds of its 12 prominent members, Vice President Dan Quayle administered the oath of office and then, after a few comments, left without introducing the advisers. Quayle was pinchhitting for the president, who, ironically, was speaking about the importance of science during a visit to two research facilities in the South.

Only after prompting from the audience did Allan Bromley, the president's science adviser and chairman of the new council, recite the credentials of his colleagues. Then they, too, were whisked away, before reporters had a chance to ask any questions.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies